Literature DB >> 4123593

Prevention of malignant exophthalmos after treatment of thyrotoxicosis.

R Winand, P Mahieu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4123593     DOI： 10.1016/s0140-6736(73)91210-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  The pathogenesis of endocrine exophthalmos: a short review.

Authors:  D Doniach
Journal:  Proc R Soc Med       Date:  1977-10

Review 2.  Immunosuppressant therapy of thyroid eye disease.

Authors:  G Kahaly; J Beyer
Journal:  Klin Wochenschr       Date:  1988-11-01

3.  Remission of hyperthyroidism.

Authors:  G A MacGregor
Journal:  Br Med J       Date:  1973-07-14

4.  Progress in endocrine exophthalmos.

Authors:  C W Havard
Journal:  Br Med J       Date:  1979-04-14

5.  Squamous cell carcinoma of the eyelid masquerading as 'malignant' ophthalmopathy of Graves's disease.

Authors:  H C Ford; J W Delahunt; C A Teague
Journal:  Br J Ophthalmol       Date:  1983-09       Impact factor: 4.638

6.  Luekocyte adherence inhibition in response to human orbital and lacrimal extracts in patients with Graves' ophthalmopathy.

Authors:  J R Wall; B A Walters; C Grant
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

7.  Cell-mediated lysis of lipid vesicles containing eye muscle protein: implications regarding pathogenesis of Graves ophthalmopathy.

Authors:  J P Kriss; S Q Mehdi
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

Review 8.  Graves' ophthalmopathy.

Authors:  J R Wall; J Henderson; C R Strakosch; D M Joyner
Journal:  Can Med Assoc J       Date:  1981-04-01       Impact factor: 8.262
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.